S. Schwarze

发表

Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma.

N. Kyprianou, S. Sakamoto, S. Schwarze, 2011, European urology.

In vivo protein transduction: delivery of a biologically active protein into the mouse.

S. Schwarze, A. Ho, S. Dowdy, 1999, Science.

In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA.

S. Schwarze, S. Dowdy, 2000, Trends in pharmacological sciences.

Protein transduction: unrestricted delivery into all cells?

K. Hruska, S. Schwarze, S. Dowdy, 2000, Trends in cell biology.

The Tumor Suppressor Par-4 Activates an Extrinsic Pathway for Apoptosis

V. Rangnekar, S. Qiu, A. Goswami, 2009, Cell.

Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells

Yan Shi, Philip A. Watson, S. Schwarze, 2001, Oncogene.

Multiple age-associated mitochondrial DNA deletions in skeletal muscle of mice

R. Weindruch, J. Aiken, S. Schwarze, 1994, Aging.

Proteasomal regulation of caspase-8 in cancer cell apoptosis

N. Kyprianou, S. Schwarze, M. Fiandalo, 2013, Apoptosis.

Differentiation associated changes in gene expression profiles of interstitial cystitis and control urothelial cells.

S. Schwarze, C. Clark, D. Erickson, 2008, The Journal of urology.

Intracellular death platform steps‐in: Targeting prostate tumors via endoplasmic reticulum (ER) apoptosis

N. Kyprianou, S. Schwarze, Eric W. Lin, 2008, The Prostate.

IRE1α controls cyclin A1 expression and promotes cell proliferation through XBP-1

S. Schwarze, Jeffery A. Thorpe, 2010, Cell Stress and Chaperones.

ErbB4 targeting approaches for prostate cancer treatment

Vivek M Rangnekar, V. Rangnekar, D. Wheeler, 2008, Cancer biology & therapy.

The Tumor Suppressor Par-4 Activates an Extrinsic Pathway for Apoptosis

V. Rangnekar, S. Qiu, A. Goswami, 2009, Cell.

Targeting plasma membrane GRP78 for cancer growth inhibition

V. Rangnekar, S. Schwarze, 2010, Cancer biology & therapy.

The identification of senescence-specific genes during the induction of senescence in prostate cancer cells.

S. Schwarze, Vivian X. Fu, D. Jarrard, 2005, Neoplasia.

Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells.

R. Weindruch, G. Wilding, S. Schwarze, 1999, Journal of the National Cancer Institute.

Oxidative stress and aging reduce COX I RNA and cytochrome oxidase activity in Drosophila.

R. Weindruch, J. Aiken, S. Schwarze, 1998, Free radical biology & medicine.

Role of Cdc37 in Overcoming p16 Mediated Growth Arrest in Prostate Cancer

S. Schwarze, 2003 .

Mutant IDH1 and thrombosis in gliomas

D. Kondziolka, J. Golfinos, G. Fatterpekar, 2016, Acta Neuropathologica.

Novel Pathways Associated with Bypassing Cellular Senescence in Human Prostate Epithelial Cells* 210

J. Brooks, S. Schwarze, Vivian X. Fu, 2002, The Journal of Biological Chemistry.

High levels of mitochondrial DNA deletions in skeletal muscle of old rhesus monkeys

R. Weindruch, J. Aiken, S. Schwarze, 1995, Mechanisms of Ageing and Development.

Proteasome inhibition blocks caspase‐8 degradation and sensitizes prostate cancer cells to death receptor‐mediated apoptosis

S. Schwarze, Perry A. Christian, Jeffery A. Thorpe, 2008, The Prostate.

A Case Study of Precision Medicine: Next Generation Sequencing Compared with Oncoscan in a Patient with Breast Cancer in Kentucky

K. Chen, S. Schwarze, R. Craven, 2019 .

Progesterone receptor membrane component 1/Sigma-2 receptor associates with MAP1LC3B and promotes autophagy

D. S. St. Clair, S. Schwarze, R. Craven, 2013, Autophagy.

Cdc37 enhances proliferation and is necessary for normal human prostate epithelial cell survival.

S. Schwarze, Vivian X. Fu, D. Jarrard, 2003, Cancer research.

Cdc 37 Enhances Proliferation and Is Necessary for Normal Human Prostate Epithelial Cell Survival 1

S. Schwarze, Vivian X. Fu, D. Jarrard, 2003 .

Role of Cdc 37 in Overcoming pl 6 Mediated Growth Arrest in Prostate Cancer 6 . AUTHORO )

S. Schwarze, 2022 .

Possible role of death receptor-mediated apoptosis by the E3 ubiquitin ligases Siah2 and POSH

Michael V. Fiandalo, S. Schwarze, M. Fiandalo, 2011, Molecular Cancer.

A Loss of Insulin-like Growth Factor-2 Imprinting Is Modulated by CCCTC-binding Factor Down-regulation at Senescence in Human Epithelial Cells*

J. Svaren, S. Schwarze, Vivian X. Fu, 2004, Journal of Biological Chemistry.

Alterations in the p16/pRb cell cycle checkpoint occur commonly in primary and metastatic human prostate cancer.

D. Heisey, A. Friedl, S. Schwarze, 2002, Cancer letters.

Activating Cell Death Ligand Signaling Through Proteasome Inhibition

S. Schwarze, 2009 .

Velcade sensitizes prostate cancer cells to TRAIL induced apoptosis and suppresses tumor growth in vivo

S. Schwarze, Perry A. Christian, Jeffery A. Thorpe, 2009, Cancer biology & therapy.

Modulation of CXCL14 (BRAK) expression in prostate cancer

W. Isaacs, Jun Luo, S. Schwarze, 2005, The Prostate.

Model system for isolation of competent ovarian-carcinoma cells from fresh tumor-tissue by a magnetic separation technique (macs).

N. Harbeck, P. Dettmar, M. Schmitt, 1995, International Journal of Oncology.

Structural determinants involved in the regulation of CXCL14/BRAK expression by the 26 S proteasome.

B. Volkman, F. Peterson, S. Schwarze, 2006, Journal of molecular biology.

Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo.

G. Waksman, S. Schwarze, A. Ho, 2001, Cancer research.

Decreased mitochondrial RNA levels without accumulation of mitochondrial DNA deletions in aging Drosophila melanogaster.

R. Weindruch, J. Aiken, S. Schwarze, 1998, Mutation research.

Cloning of a Functional Thrombin Receptor Reveals a Novel Proteolytic Mechanism of Receptor Activation” by Thien

S. Coughlin, S. Schwarze, K. Vu, 2017 .